Corbus Pharmaceuticals Reports 2017 Second Quarter Financial Results and Provides Business Update
NORWOOD, MA--(Marketwired - August 09, 2017) - Data from Phase 2 open-label extension study of anabasum for the treatment of systemic sclerosis expected in Q4 2017 Phase 3 study of anabasum for the treatment of system sclerosis expected to commence in Q4 …